Ramos Eleanor

CIK 00014649073 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001464907

Recent Transactions

32 trades

Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−460,462→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−210,000→ 0 total
Disposition from Tender
Provention Bio, Inc.
Common Stock
2023-04-27−70,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−400,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−145,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−137,750→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−139,500→ 0 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2023-01-10+210,000→ 210,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-12-08+20,663→ 75,763 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-11-22+80,000→ 400,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-01-18+145,000→ 145,000 total
Purchase
Provention Bio, Inc.
Common Stock
2021-12-03$6.49/sh+5,201→ 70,000 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2021-05-12+139,500→ 139,500 total
Purchase
Provention Bio, Inc.
Common Stock
2020-09-02$12.06/sh+299→ 64,799 total
Purchase
Provention Bio, Inc.
Common Stock
2020-08-20$13.23/sh+2,500→ 64,500 total
Award
Provention Bio, Inc.
Option (right to buy)
2020-07-15+137,750→ 137,750 total
Purchase
Provention Bio, Inc.
Common Stock
2019-12-26$14.34/sh+2,000→ 62,000 total
Award
Provention Bio, Inc.
Option (right to buy)
2019-06-24+400,000→ 400,000 total
Purchase
Provention Bio, Inc.
Common Stock, par value $0.0001 per share
2018-07-19$4.00/sh+60,000→ 60,000 total
Award
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-09-29+9,286→ 9,286 total
Award
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2016-03-10+9,286→ 9,286 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2016-02-01$16.09/sh+1,470→ 12,470 total
Purchase
Global Blood Therapeutics, Inc.
Common Stock
2015-12-22$30.28/sh+1,000→ 11,000 total
Purchase
Global Blood Therapeutics, Inc.
Common Stock
2015-12-22$30.28/sh+1,000→ 11,000 total
Purchase
Global Blood Therapeutics, Inc.
Common Stock
2015-08-17$20.00/sh+10,000→ 10,000 total
Purchase
Global Blood Therapeutics, Inc.
Common Stock
2015-08-17$20.00/sh+10,000→ 10,000 total
Purchase
Global Blood Therapeutics, Inc.
Common Stock
2015-08-17$20.00/sh+1,000→ 1,000 total
Disposition from Tender
ZYMOGENETICS INC
Common Stock
2010-10-08$9.75/sh−3,599→ 2,500 total
Sale
ZYMOGENETICS INC
Common Stock
2010-02-24$5.66/sh−662→ 6,099 total
Award
ZYMOGENETICS INC
Stock Option (Right to Buy)
2010-01-29+48,150→ 48,150 total
Disposition to Issuer
ZYMOGENETICS INC
Stock Option (Right to Buy)
2009-12-16−50,000→ 0 total
Award
ZYMOGENETICS INC
Stock Option (Right to Buy)
2009-12-16+28,570→ 28,570 total

Companies

Recent Filings

Address

C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE EAST

SEATTLE, WA, 98102

View on SEC.gov